Results 71 to 80 of about 6,452 (220)

Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma

Frontiers in Nuclear Medicine
BackgroundTransarterial radioembolization (TARE) using Yttrium-90 microspheres has emerged as a promising locoregional therapy for patients with advanced hepatocellular carcinoma (HCC).
Hongyin Lin, Quanhui Tan
doaj   +1 more source

TARE and PVE as pre-operative strategies in highly selected patients with primary and metastatic hepatic malignancies [PDF]

, 2022
Júlia Pedó Freitas, Pradeep S. B. Podila, Daniel K. Powell, Wes Angel, Jeremiah L. Deneve, Paxton V. Dickson, Evan S. Glazer   +6 more
openalex   +1 more source

Sélection zygotique et tares récessives autosomiques dans une population finie [PDF]

, 1979
Gérard GÉRY
openalex   +1 more source

TARE: A Hierarchical Framework for Efficiently Exploring Complex 3D Environments

, 2021
Chao Cao, Hongbiao Zhu, Howie Choset, Ji Zhang   +3 more
openalex   +1 more source

DATA FOLDER - Tradeoff Analysis of Residential retrofits for Energy equity (TARE) Model

Joseph, Jordan
  +4 more sources

VISQUEEN film liners cut tare weight costs up to 70%—assure 100% product recovery! [PDF]

, 1954

openalex   +1 more source

Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation

EJNMMI Research
Background Relatively high mean absorbed doses to the non-tumorous liver tissue (NTLT) are generally well tolerated in transarterial radioembolisation (TARE), potentially due to a heterogeneous dose distribution.
Anne van den Brekel, Tess J. Snoeijink, Vincent E. de Meijer, Milou Boswinkel, Koert P. de Jong, Joey Roosen, Alexandra G. Arranja, Jurgen J. Fütterer, Simeon J. S. Ruiter, J. Frank W. Nijsen   +9 more
doaj   +1 more source

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis

Frontiers in Oncology
BackgroundCurrently, inoperable hepatocellular carcinoma (HCC) is treated by both transarterial radioembolization (TARE) and transarterial chemoembolization (TACE). However, their relative efficacy and outcomes remain unclear. This meta-analysis aimed to
Wenxiao Lu, Tongsheng Zhang, Fengfei Xia, Xiangzhong Huang, Fulei Gao, Fulei Gao   +5 more
doaj   +1 more source

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments

Journal of Hepatocellular Carcinoma, 2014
Alberta Cappelli,1 Cinzia Pettinato,2 Rita Golfieri1 1Radiology Unit, 2Medical Physics Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum – University of Bologna, S Orsola-Malpighi Hospital, Bologna, Italy Abstract: A ...
Cappelli A, Pettinato C, Golfieri R
doaj  

Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection

Journal of Clinical Interventional Radiology ISVIR
Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to
Amelia Wong, Shirley Cheng, Anthony Herrera, Linda Wong   +3 more
doaj   +1 more source